Real-World Experience in the Use of Immunosuppression for the Management of Inflammatory Eye Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-World Experience in the Use of Immunosuppression for the Management of Inflammatory Eye Disease

Published:2024-02-13 Issue: Volume: Page:1-10
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Azzopardi Matthew¹²,Chong Yu Jeat¹,Sreekantam Sreekanth¹,Barry Robert J.¹²,Poonit Natraj¹²,Rauz Saaeha¹²,Murray Philip I.¹²

Affiliation:

1. Centre for Inflammatory Eye Disease, Birmingham and Midland Eye Centre, Sandwell and West Birmingham NHS Trust, Birmingham, UK

2. Academic Unit of Ophthalmology, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK

Funder

UKRI Medical Research Council

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2024.2311743

Reference62 articles.

1. Immunosuppressive Therapy for Ocular Mucous Membrane Pemphigoid

2. Update on ocular cicatricial pemphigoid and emerging treatments

3. Uveitis: A Potentially Blinding Disease

4. Degree, duration, and causes of visual loss in uveitis

5. Causes and frequency of blindness in patients with intraocular inflammatory disease.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP